Best GLP-1 Options Without Insurance in 2026

Brand-name Wegovy costs over $1,300/month without insurance. Zepbound is not much better. For millions of Americans who want GLP-1 therapy but do not have coverage, that price tag makes these medications effectively inaccessible through traditional channels.

But the market has responded. Compounded GLP-1 programs, manufacturer savings cards, and cash-pay telehealth clinics have opened up real alternatives. We evaluated the best options for patients paying out of pocket in 2026.

Our Top Picks

1. Henry Meds : Cheapest reliable option for compounded semaglutide without insurance
2. Ro Body : Best medical oversight for uninsured patients
3. Form Blends : Best physician-supervised compounded GLP-1 program for cash-pay patients
4. Hims/Hers : Best high-volume cash-pay platform
5. Manufacturer Savings Programs : Worth checking before going compounded

---

Detailed Reviews

#1. Henry Meds : $149/month

For uninsured patients whose primary concern is cost, Henry Meds delivers compounded semaglutide at $149/month with no separate consult fees or hidden charges. The enrollment process is simple, the medication ships quickly, and the monthly provider check-ins keep you within the bounds of medical supervision.

The care is not deeply personalized. But at this price point, with medication included, Henry Meds removes the biggest barrier that keeps uninsured patients from accessing GLP-1 therapy.

Pros:

• $149/month, all-in, for compounded semaglutide
• No insurance required
• Simple enrollment and fast shipping
• No hidden fees

Cons:

• Basic medical oversight
• No lab monitoring included
• No coaching or lifestyle support

#2. Ro Body : $149 to $249/month

Ro provides the best medical care among cash-pay GLP-1 programs. Lab monitoring is part of the protocol, physicians adjust dosing based on objective data, and the in-house pharmacy adds a layer of quality control that matters when you are using compounded medications.

Starting doses are $149/month, but costs increase as you titrate up. For uninsured patients willing to pay a moderate premium for better clinical care, Ro is the strongest option.

Pros:

• Lab-based monitoring included
• In-house pharmacy
• Physician-led care with real oversight
• Competitive starting prices

Cons:

• Costs increase significantly at higher doses
• Not available in every state
• No coaching component

#3. Form Blends : $199/month

Form Blends serves a lot of uninsured patients, and their program is designed with cash-pay access in mind. The $199/month subscription includes compounded semaglutide (or tirzepatide at $249/month), physician supervision, and ongoing dosing adjustments.

What uninsured patients particularly appreciate about Form Blends is the clinical engagement. Without a PCP managing your care alongside the program, having a physician who actively monitors your response and adjusts your protocol becomes even more important. Form Blends provides that level of oversight.

Pros:

• Built for cash-pay patients
• Active physician oversight compensates for lack of PCP involvement
• Personalized dosing protocols
• Peptide therapy options available

Cons:

• $50/month more than the cheapest option
• No brand-name prescriptions
• Smaller operation

#4. Hims/Hers : $175/month

Hims/Hers offers compounded semaglutide at $175/month in a polished cash-pay experience. No insurance needed, no complex enrollment. The platform works well, messaging is responsive, and fulfillment is fast.

For uninsured patients who value a smooth digital experience and do not need deeply personalized care, Hims/Hers hits a good balance of price and usability.

Pros:

• Clean, well-built platform
• $175/month with medication included
• No insurance paperwork
• Fast fulfillment

Cons:

• Care can feel impersonal
• Provider continuity is limited
• Cancellation policies are restrictive

#5. Manufacturer Savings Programs

Before committing to a compounded program, check whether you qualify for manufacturer savings cards. Novo Nordisk offers savings programs for Wegovy, and Eli Lilly has programs for Zepbound. Eligibility typically requires that you have commercial insurance that does not cover the medication (not uninsured entirely), but the rules have evolved and some programs now extend to uninsured patients with qualifying income levels.

These programs can reduce brand-name costs to $0 to $500/month, though eligibility restrictions apply and coverage can change with little notice.

Pros:

• Can dramatically reduce brand-name costs
• FDA-approved medications
• No compounding involved

Cons:

• Eligibility is inconsistent and hard to predict
• Programs can change or end without warning
• Often requires some form of insurance (even without coverage for the specific drug)
• Still expensive for many patients even with savings cards

---

How We Evaluated

For uninsured patients, we adjusted our evaluation criteria to emphasize what matters most when you are paying entirely out of pocket:

• Total monthly cost (35%): The single most important factor for uninsured patients. We calculated all-in costs including medication, consultations, and shipping.
• Medical safety (25%): When you do not have a PCP managing your broader health, the quality of medical oversight from your GLP-1 provider matters more. We assessed monitoring, lab work, and clinical responsiveness.
• Pharmacy quality (20%): 503B compliance, transparency about sourcing, and medication quality
• Pricing predictability (10%): Whether your costs stay stable as you titrate up, or whether you face surprise increases
• Cancellation flexibility (10%): Uninsured patients need the ability to pause or stop if financial circumstances change

FAQ

Is it safe to use GLP-1 medications without insurance or a primary care doctor?

It can be, as long as your prescribing provider conducts a thorough medical evaluation and monitors you appropriately. The programs on this list all include physician oversight. However, if you have existing health conditions (heart disease, thyroid issues, pancreatitis history), you should ideally have a primary care relationship alongside any telehealth program.

Why is brand-name semaglutide so expensive without insurance?

Novo Nordisk sets the list price for Wegovy at over $1,300/month, reflecting their investment in clinical trials, manufacturing, and regulatory approval. Without insurance negotiating a lower rate, patients bear the full cost. This is why compounded alternatives have become so popular for cash-pay patients.

Are compounded GLP-1s as effective as brand-name?

When produced by 503B-compliant pharmacies, compounded semaglutide contains the same active ingredient as Wegovy and should produce equivalent results. The FDA does not formally approve compounded medications, but 503B pharmacies operate under strict regulatory oversight. Every program on this list uses 503B pharmacies.

What if I cannot afford even compounded GLP-1s?

Non-GLP-1 weight loss medications like metformin and bupropion-naltrexone (Contrave) are available as generics and cost $30 to $80/month. Programs like Found offer these alternatives. They are less effective than GLP-1s on average, but they are real options for patients on tight budgets.

Will GLP-1 prices come down?

Probably, but slowly. Increased competition (tirzepatide, survodutide, orforglipron), political pressure, and the growth of the compounding market are all pushing toward lower prices. Generic semaglutide is still years away, but the trajectory is downward.

---

Need GLP-1 therapy without insurance? Form Blends offers affordable, physician-supervised compounded GLP-1 programs designed for cash-pay patients.